China Regenerative Medicine International Limited, together with its subsidiaries, engages in the research, development, production, and sale of tissue engineering and regenerative medicine products in Hong Kong and China. It operates in two segments, Aesthetic Medical and Beauty Services, and Medical Services. The company offers anti-aging /prevention, functional medicine and solutions, and treatment and diagnosis; hair regenerating medical solutions; and zoom consultation, mental fog therapy, physiotherapy, acnes treatment, and facial and slimming acupuncture services. It also provides skin regeneration, body function refining, Chinese/medical aesthetics, slimming and detoxing, and uterine and circulation services; endoscopy and scar removal services; and medical tests and vaccines. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in February 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
Frequently asked questions
What sector does China Regenerative Medicine International Ltd (8158) operate in?
China Regenerative Medicine International Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is China Regenerative Medicine International Ltd (8158) current stock price?
As of the latest data, China Regenerative Medicine International Ltd stock price is HK$0.25, with a previous close of HK$0.22. China Regenerative Medicine International Ltd gained HK$0.03 in the last trading session, representing a 11.82% increase.
What is China Regenerative Medicine International Ltd (8158) current market capitalization?
China Regenerative Medicine International Ltd market cap is approximately 74.85 million.
What is China Regenerative Medicine International Ltd (8158) EBITDA?
China Regenerative Medicine International Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 10.09 million.
Does China Regenerative Medicine International Ltd (8158) pay dividends?
No. China Regenerative Medicine International Ltd does not pay a dividend.
What is China Regenerative Medicine International Ltd (8158) beta (volatility) score?
China Regenerative Medicine International Ltd has a beta of -0.963, indicating lower volatility than the overall market.
